131 related articles for article (PubMed ID: 38615585)
21. The existence of early stage oral mucosal melanoma: A 10-year retrospective analysis of 170 patients in a single institute.
Wu Y; Wang L; Ma X; Guo W; Ren G
Oral Oncol; 2018 Dec; 87():70-76. PubMed ID: 30527246
[TBL] [Abstract][Full Text] [Related]
22. Treatment and prognosis of oral mucosal melanoma.
Sun CZ; Chen YF; Jiang YE; Hu ZD; Yang AK; Song M
Oral Oncol; 2012 Jul; 48(7):647-52. PubMed ID: 22349277
[TBL] [Abstract][Full Text] [Related]
23. Analysis of nicotinamide N-methyltransferase in oral malignant melanoma and potential prognostic significance.
Mascitti M; Santarelli A; Sartini D; Rubini C; Colella G; Salvolini E; Ganzetti G; Offidani A; Emanuelli M
Melanoma Res; 2019 Apr; 29(2):151-156. PubMed ID: 30431528
[TBL] [Abstract][Full Text] [Related]
24. C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma.
Rivera RS; Nagatsuka H; Gunduz M; Cengiz B; Gunduz E; Siar CH; Tsujigiwa H; Tamamura R; Han KN; Nagai N
Virchows Arch; 2008 Jan; 452(1):27-32. PubMed ID: 18066592
[TBL] [Abstract][Full Text] [Related]
25. Meta-Analysis and Systematic Review of the Genomics of Mucosal Melanoma.
Broit N; Johansson PA; Rodgers CB; Walpole ST; Newell F; Hayward NK; Pritchard AL
Mol Cancer Res; 2021 Jun; 19(6):991-1004. PubMed ID: 33707307
[TBL] [Abstract][Full Text] [Related]
26. Periodic acid-Schiff-positive loops and networks as a prognostic factor in oral mucosal melanoma.
Song H; Jing G; Wang L; Guo W; Ren G
Melanoma Res; 2016 Apr; 26(2):145-52. PubMed ID: 26636907
[TBL] [Abstract][Full Text] [Related]
27. Immunolocalization and distribution patterns of type IV collagen alpha chains in oral mucosal melanoma.
Nagatsuka H; Santos Rivera R; Gunduz M; Lee YJ; Tamamura R; Gunduz E; Naito I; Sado Y; Nagai N
Virchows Arch; 2005 Oct; 447(4):710-6. PubMed ID: 16047187
[TBL] [Abstract][Full Text] [Related]
28. Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations.
Williams EA; Montesion M; Shah N; Sharaf R; Pavlick DC; Sokol ES; Alexander B; Venstrom J; Elvin JA; Ross JS; Williams KJ; Tse JY; Mochel MC
Mod Pathol; 2020 Dec; 33(12):2397-2406. PubMed ID: 32483240
[TBL] [Abstract][Full Text] [Related]
29. Distinct genomic traits of acral and mucosal melanomas revealed by targeted mutational profiling.
Zou Z; Ou Q; Ren Y; Lv Q; Qin L; Zhao L; Su S; Wu X; Bao H; Wang A; Zhu D; Wang X; Shao YW; Liu B
Pigment Cell Melanoma Res; 2020 Jul; 33(4):601-611. PubMed ID: 31944535
[TBL] [Abstract][Full Text] [Related]
30. Tumor size and depth in primary malignant melanoma in the oral cavity influences survival.
Mücke T; Hölzle F; Kesting MR; Loeffelbein DJ; Robitzky LK; Hohlweg-Majert B; Tannapfel A; Wolff KD
J Oral Maxillofac Surg; 2009 Jul; 67(7):1409-15. PubMed ID: 19531410
[TBL] [Abstract][Full Text] [Related]
31. Predominance of triple wild-type and IGF2R mutations in mucosal melanomas.
Iida Y; Salomon MP; Hata K; Tran K; Ohe S; Griffiths CF; Hsu SC; Nelson N; Hoon DSB
BMC Cancer; 2018 Oct; 18(1):1054. PubMed ID: 30373548
[TBL] [Abstract][Full Text] [Related]
32. Loss of nuclear BAP1 expression is associated with poor prognosis in oral mucosal melanoma.
Song H; Wang L; Lyu J; Wu Y; Guo W; Ren G
Oncotarget; 2017 Apr; 8(17):29080-29090. PubMed ID: 28404968
[TBL] [Abstract][Full Text] [Related]
33. Primary oral mucosal melanoma: advocate a wait-and-see policy in the clinically N0 patient.
Wang X; Wu HM; Ren GX; Tang J; Guo W
J Oral Maxillofac Surg; 2012 May; 70(5):1192-8. PubMed ID: 21783300
[TBL] [Abstract][Full Text] [Related]
34. Targeted next-generation sequencing of Japanese patients with sinonasal mucosal melanomas identifies frequent NRAS and CTNNB1 mutations.
Tsushima N; Kano S; Hatanaka KC; Suzuki T; Hamada S; Idogawa H; Nakamaru Y; Suzuki M; Hatanaka Y; Homma A
Auris Nasus Larynx; 2024 Apr; 51(2):313-319. PubMed ID: 37953090
[TBL] [Abstract][Full Text] [Related]
35. Targeted Genomic Profiling of Acral Melanoma.
Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
[TBL] [Abstract][Full Text] [Related]
36. CD117 immunoexpression in oral and sinonasal mucosal melanoma does not correlate with somatic driver mutations in the MAPK pathway.
Maldonado-Mendoza J; Ramírez-Amador V; Anaya-Saavedra G; Ruíz-García E; Maldonado-Martínez H; Fernández Figueroa E; Meneses-García A
J Oral Pathol Med; 2019 May; 48(5):382-388. PubMed ID: 30873641
[TBL] [Abstract][Full Text] [Related]
37. BRAF, NRAS, KIT, TERT, GNAQ/GNA11 mutation profile analysis of head and neck mucosal melanomas: a study of 42 cases.
Öztürk Sari Ş; Yilmaz İ; Taşkin OÇ; Narli G; Şen F; Çomoğlu Ş; Firat P; Bİlgİç B; Yilmazbayhan D; Özlük Y; Büyükbabanİ N
Pathology; 2017 Jan; 49(1):55-61. PubMed ID: 27914687
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients.
Sakaizawa K; Ashida A; Uchiyama A; Ito T; Fujisawa Y; Ogata D; Matsushita S; Fujii K; Fukushima S; Shibayama Y; Hatta N; Takenouchi T; Uehara J; Okuyama R; Yamazaki N; Uhara H
J Dermatol Sci; 2015 Oct; 80(1):33-7. PubMed ID: 26282084
[TBL] [Abstract][Full Text] [Related]
39. Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma.
Hou JY; Baptiste C; Hombalegowda RB; Tergas AI; Feldman R; Jones NL; Chatterjee-Paer S; Bus-Kwolfski A; Wright JD; Burke WM
Cancer; 2017 Apr; 123(8):1333-1344. PubMed ID: 28026870
[TBL] [Abstract][Full Text] [Related]
40. Neck dissection for oral mucosal melanoma: caution of nodular lesion.
Wu Y; Zhong Y; Li C; Song H; Guo W; Ren G
Oral Oncol; 2014 Apr; 50(4):319-24. PubMed ID: 24548569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]